(Q34768798)

4 August 2017

1 reference

title

Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic (English)

1 reference

4 August 2017

Steven C Schachter

1

1 reference

4 August 2017

publication date

1 June 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

50

1 reference

4 August 2017

issue

1-2

1 reference

4 August 2017

page(s)

67-70

1 reference

Relapse following discontinuation of antiepileptic drugs: a meta-analysis

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Do seizures beget seizures? An assessment of the clinical evidence in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Comparison between one and three years of treatment in uncomplicated childhood epilepsy: a prospective study. I. Outcome in different seizure types

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

The process of epileptogenesis: a pathophysiological approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Can anticonvulsant drug therapy "cure" epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. First Seizure Trial Group (FIR.S.T. Group)

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Remission of seizures in untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Prevalence of the epilepsies in Nigerian Africans: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

A large-scale study of epilepsy in Ecuador: methodological aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Some aspects of prognosis in the epilepsies: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Does antiepileptic drug therapy prevent the development of "chronic" epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Clinical and electroencephalographic characteristics of epilepsy in rural Ethiopia: a community-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

Epileptics not in treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2802%2900069-4

7 January 2021

10.1016/S0920-1211(02)00069-4

Identifiers

DOI

1 reference

4 August 2017

1 reference